Palvella Therapeutics Files Q1 2025 10-Q

Ticker: PVLA · Form: 10-Q · Filed: May 15, 2025 · CIK: 1583648

Palvella Therapeutics, Inc. 10-Q Filing Summary
FieldDetail
CompanyPalvella Therapeutics, Inc. (PVLA)
Form Type10-Q
Filed DateMay 15, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, pharmaceuticals, financial-reporting

Related Tickers: PVLA

TL;DR

**Palvella Therapeutics (PVLA) filed its Q1 2025 10-Q. Formerly Pieris Pharma.**

AI Summary

Palvella Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Pieris Pharmaceuticals, Inc., is incorporated in Nevada and operates in the pharmaceutical preparations sector. Their business address is located in Wayne, PA.

Why It Matters

This filing provides investors with an update on Palvella Therapeutics' financial performance and operational status for the first quarter of 2025.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Palvella Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

  • 20250331 — Reporting Period End (The 10-Q covers financial information up to this date.)
  • 20250515 — Filing Date (The date the report was officially submitted to the SEC.)

Key Players & Entities

  • PALVELLA THERAPEUTICS, INC. (company) — Filer
  • Pieris Pharmaceuticals, Inc. (company) — Former company name
  • 20250331 (date) — Reporting period end date
  • 20250515 (date) — Filing date
  • Wayne, PA (location) — Business address city and state

FAQ

What was Palvella Therapeutics' former name?

Palvella Therapeutics, Inc. was formerly known as Pieris Pharmaceuticals, Inc., with a name change effective December 13, 2024.

What is the fiscal year end for Palvella Therapeutics?

Palvella Therapeutics' fiscal year ends on December 31.

In which state is Palvella Therapeutics incorporated?

Palvella Therapeutics is incorporated in Nevada (NV).

What is the SIC code for Palvella Therapeutics?

The Standard Industrial Classification (SIC) code for Palvella Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.

What is the business address of Palvella Therapeutics?

The business address for Palvella Therapeutics is 125 Strafford Ave, Suite 360, Wayne, PA 19087.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding PALVELLA THERAPEUTICS, INC. (PVLA).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.